To translate novel biologic therapeutics from the bench to the bedside, a recent thread of our RA research involves the assessment of literacy, factors that influence patient decision quality, patient skills to interpret risk, and the development of decision aids to support patient choice.   We have published our work in a variety of peer reviewed journals including: J Rheumatology, Arthritis Rheumatism, Patient Education & Counseling and Medical Decision Making. In addition, our work has been promoted by Medscape.com, MyCME.com, The Rheumatologist as well as at numerous national academic meetings.

We have listed only a few of our publications which are linked their abstracts at the National Library of Medicine.

Martin RW, Wanke LE.  Etanercept Plus a Patient Education and Support System Improve Health Related Quality of Life in Rheumatoid Arthritis Patients in a Clinical Setting.  Arthritis Rheum 2003;48:S424.

Martin RW, Raykov T, Head AJ, Feichtner J,  Holmes-Rovner M. Rheumatoid Arthritis DMARD Knowledge Profile: Development and Validation. Arthritis Rheum 2006;54:S700.

Martin RW, Swartz T , McIntyre B, Holmes-Rovner M. Effectiveness of Disease Modifying Anti-rheumatic Drug Risk Communication in Rheumatoid Arthritis.  Arthritis Rheum 2006;54:S369.

Martin RW, Bader LA Head AJ Turbergen EJ, Holmes-Rovner M.  Identifying Patients Who Need Low Literacy Materials to Support Anti-Rheumatic Drug Decision Making.  Arthritis Rheum 2007;56:S109.

Martin RW, Holmes-Rovner M, Raykov T.  Does Depression Modify Patient Appraisal of Anti-rheumatic Drug Treatment Effects? Society for Medical Decision Making Pittsburg, PA 2007.

Martin RW, Head AJ, Holmes-Rovner M.  Ability to Interpret Statements of Numeric Risk and Patient Satisfaction with Anti-Rheumatic Risk Communication.  Society for Medical Decision Making Pittsburg, PA 2007.

Martin RW, Head AH, Birmingham JB, Eggebeen AT. Gregory JK. Use of Patient Historical Clues to Predict Weekly Raynauds Condition Score Measured by Electronic Digital Diary. Arthritis Rheum 2008;59:S.

Martin RW, Head AJ, Rene J, Swartz TJ, Fiechtner JJ, McIntosh BA, Holmes-Rovner M. Patient Decision Making of Anti-Rheumatic Drugs: The Importance of Patient Trust of Physician.   J. Rheumatology 2008; 35:615-24.

Martin RW, Gallagher PJ, Eggebeen AT, Head AJ. A Decision Aid for Rheumatoid Arthritis Patients Considering Methotrexate Therapy. Arthritis Rheum 2009;60:S324.

Martin RW, Gallagher PJ, Tellinghuisen DJ. Can the Results of Laboratory Based Message Framing Experiments Be Generalized to Patients?  Plenary presentation Society for Medical Decision Making. Chicago, IL. 2011.

Martin RW, Head  AJ., Birmingham JD, Eggebeen AT. Does Biased Risk Perception Explain the Underuse of Disease Modifying Anti-Rheumatic Drugs? Arthritis Rheum 2012;64 Suppl 10 :382 DOI: 10.1002/art.38117.

Martin RW, Brower ME, Geralds A, Gallagher PJ, Tellinghuisen DJ. An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis. Patient Educ Couns 2012; 86: 331-336. 

Martin RW.  Communicating the Risk of Side Effects to Patients with Rheumatic Diseases. InCush J and Dao K. Rheumatic Disease Clinics of North America. Therapeutic Toxicities in Rheumatic Disease Patients. 2012;38(4):653-62.

Feldman-Stewart D, O’Brien MA, Clayman M, Davison J, Jimbo M, Labrecque M, Martin RW, Shepherd H. Providing Information About Options. BMC Med Inform Decis Mak. 2013;13(Suppl 2):54. DOI:http://www.biomedcentral.com/1472-6947/13/S2/S4

Martin RW, McCallops K, Head AJ, Eggebeen AE, Birmingham JD, Tellinghuisen DJ. Influence of Patient Characteristics on Perceived Risks and  Willingness to Take a Proposed Disease Modifying Anti-rheumatic Drug. BMC Medical Informatics and Decision Making 2013; 13:89:1-9. DOI:10.1186/1472-6947-13-89.

Martin RW, Enck RD, Tellinghuisen DJ, Eggebeen AT, Birmingham JD, Head AJ. Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis Med Decis Mak 2017;37(5):577-588.

Nallani R, Martin RW. Decisional Conflict in Doctor – Patient Discussions about Disease Modifying Anti-rheumatic Drugs.  Arthritis Rheum 2017; 69 (suppl 10).

Martin RW, Nallani R, Head AD, Eggebeen AT, Birmingham JD, Slavin ET. Patient Beliefs and Preference to Start a Proposed Medication in Rheumatoid Arthritis. Arthritis Rheum 2017; 69 (suppl 10).